EP1504115A1 - Verfahren und reagenzsystem mit nicht-regenerierbarem enzym-coenzym-komplex - Google Patents

Verfahren und reagenzsystem mit nicht-regenerierbarem enzym-coenzym-komplex

Info

Publication number
EP1504115A1
EP1504115A1 EP03732396A EP03732396A EP1504115A1 EP 1504115 A1 EP1504115 A1 EP 1504115A1 EP 03732396 A EP03732396 A EP 03732396A EP 03732396 A EP03732396 A EP 03732396A EP 1504115 A1 EP1504115 A1 EP 1504115A1
Authority
EP
European Patent Office
Prior art keywords
coenzyme
enzyme
analyte
reagent
dehydrogenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03732396A
Other languages
German (de)
English (en)
French (fr)
Inventor
Carina Horn
Joachim Hoenes
Wolfgang-Reinhold Knappe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002121845 external-priority patent/DE10221845A1/de
Priority claimed from DE2002121846 external-priority patent/DE10221846A1/de
Priority claimed from DE2002121840 external-priority patent/DE10221840A1/de
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Publication of EP1504115A1 publication Critical patent/EP1504115A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/002—Electrode membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Definitions

  • the invention relates to a method and a reagent system for the detection of an analyte in a sample by an enzymatic reaction, comprising the use of an enzyme-coenzyme complex as a non-regenerable, in particular stoichiometric reaction partner for the analyte present in the sample.
  • analytes for example glucose in blood
  • enzymatic methods The detection of analytes, for example glucose in blood, by enzymatic methods is known.
  • the analyte to be determined is brought into contact with a suitable enzyme and a coenzyme, the enzyme being used in catalytic quantities.
  • the redox equivalents that result from the reduction or oxidation of the coenzyme are transferred to mediators, which are then recorded electrochemically or photometrically in a further step.
  • a calibration provides a direct relationship between the measured value and the concentration of the analyte to be determined.
  • Narayanaswamy et al. (Analytical Letters 21 (7) (1988), 1 165-1 175) describe a fluorescence measurement with glucose dehydrogenase and NAD for the determination of glucose.
  • the enzyme is used in catalytic, ie non- stoichiometric, amounts used.
  • the fluorescence measurement detects the free NADH in the solution.
  • the analytes to be determined can only be determined indirectly, i.e. through several chemical reactions. This often requires a complicated adjustment of the concentrations of the substances involved in order to optimize the reaction rate. There is also the risk that the required electrochemically active substances are unstable after prolonged storage.
  • the mediators often have to be used in large excess compared to the enzyme-coenzyme system.
  • the coenzyme has a high reactivity, so that the enzyme activity when the mediator disintegrates even in small amounts, e.g. ⁇ 1% or when exposed to foreign substances, e.g. B. evaporation of the substances from packaging materials decreases significantly. This can lead to incorrect signals in the analyte determination.
  • the determination times for the analyte are usually in the range of at least a few seconds, for glucose e.g. be in the range of> 4 s, and the required sample volumes are large, e.g. > 0.5 ⁇ l.
  • the object underlying the present invention was to at least partially avoid the disadvantages of the prior art described.
  • an insensitive and fast method for the enzymatic detection of analytes should be provided, which leads to reliable measurement results even in the absence of mediators and / or indicators.
  • This object is achieved in that an enzyme-coenzyme complex is used as a stoichiometric reaction partner instead of, as is usually the case, as a catalyst.
  • the detection of the analyte requires only a single reaction step and is therefore extremely fast.
  • mediators and indicators combined with the use of complex reagent mixtures, with low stability and high susceptibility to faults, is no longer necessary.
  • the invention thus relates to a method for the detection of an analyte in a sample by an enzymatic reaction, comprising the steps:
  • Another object of the invention is a reagent system for the detection of an analyte in a sample, comprising: (a) a detection reagent comprising an enzyme-coenzyme complex, wherein no regeneration of the coenzyme takes place, and
  • the present invention enables simple qualitative or quantitative determination of analytes within a very short reaction time of preferably ⁇ 5 s, particularly preferably 1 1 s, most preferably ⁇ 0.1 s.
  • the reaction is carried out under conditions in which there is no regeneration of the coenzyme during the determination.
  • a molecular enzyme-coenzyme complex can only react with a single molecule of the analyte.
  • the reaction is therefore expedient in the absence of mediators or others Substances carried out that can cause regeneration of the coenzyme.
  • the detection reagent contains the enzyme-coenzyme complex in a sufficient amount to enable a qualitative and / or quantitative determination of the analyte according to the desired test format.
  • the enzyme-coenzyme complex is used in a quantity, in particular for a quantitative determination of the analyte, so that the number of reacting molecules of the enzyme-coenzyme complex correlates with the analyte concentration present in the sample.
  • the enzyme-coenzyme complex is particularly preferably used in an at least stoichiometric amount with respect to the analyte present in the sample, preferably in a stoichiometric excess with respect to the analyte.
  • the expression “in at least a stoichiometric amount” means that the size of the sample is matched to the number of molecules of the enzyme-coenzyme complex in such a way that, for the analyte concentrations to be expected in the sample, the number of molecules of the Enzyme-coenzyme complex correlated with the analyte concentration present in the sample.
  • "Stoichiometric amount” preferably means that the number of molecules of the enzyme-coenzyme complex corresponds to the maximum number of analyte molecules to be expected in the examined sample.
  • the method and the detection system allow the use of very small sample amounts, for example sample volumes ⁇ 1 ⁇ ⁇ , in particular ⁇ 0.1 ⁇ ⁇ . If necessary, the sample can be diluted before contact with the detection reagent.
  • the method and detection system according to the invention is suitable for determining any analytes, for example parameters in
  • Body fluids such as blood, serum, plasma or urine, but also in
  • Sewage samples or food can be used both as Wet test, for example in a cuvette, or as a dry test on an appropriate reagent carrier.
  • Any biological or chemical substances that can react with an enzyme-coenzyme complex in particular a redox reaction, such as glucose, lactic acid, malic acid, glycerol, alcohol, cholesterol, triglycerides, ascorbic acid, cysteine, glutathione, can be determined as analytes. Peptides etc.
  • the enzymatic reaction is preferably a redox reaction in which the coenzyme is reduced or oxidized in the enzyme-coenzyme complex.
  • An oxidoreductase is preferably used as the enzyme for such a reaction.
  • the enzyme used is particularly preferably a dehydrogenase, for example selected from a glucose dehydrogenase (EC1.1.1.47), lactate dehydrogenase (EC1.1.1.27, 1.1 .1.28), malate dehydrogenase (EC1.1.1 .37), glycerol -Dehydrogenase (EC1.1 .1 .6), alcohol dehydrogenase (EC1.1 .1.1) or amino acid dehydrogenase, e.g.
  • L-amino acid dehydrogenase (E.C.1 .4.1.5).
  • Other suitable enzymes are oxidases, such as glucose oxidase (E.C.1.1 .3.4) or cholesterol oxidase (E.C.1 .1.3.6).
  • Coenzymes in the sense of the present invention are preferably organic molecules which are covalently or non-covalently bound to an enzyme and which are changed, for example oxidized or reduced, by the reaction of the analyte.
  • Preferred examples of coenzymes are flavin, nicotin and quinone derivatives, for example flavin nucleoside derivatives such as FAD, FADH 2 , FMN, FMNH 2 , etc., nicotine nucleoside derivatives such as NAD + , NADH / H + , NADP + , NADPH / H + etc or ubiquinones such as coenzyme Q, PQQ etc.
  • the change in the coenzyme by reaction with the analyte can in principle be detected in any manner.
  • all methods known from the prior art for the detection of enzymatic reactions can be used.
  • the change in the coenzyme is preferably detected by optical methods.
  • Optical detection methods include, for example, the measurement of absorption, fluorescence, circular dichroism (CD), optical rotation dispersion (ORD), refractometry, etc.
  • the change in the coenzyme is particularly preferably detected by measuring the fluorescence.
  • the fluorescence measurement is highly sensitive and enables the detection of even low concentrations of the analyte in miniaturized systems.
  • the method or detection system according to the invention can comprise a liquid test, the reagent e.g. is in the form of a solution or suspension in an aqueous or non-aqueous liquid or as a powder or lyophilisate.
  • the method and detection system according to the invention preferably include a dry test, the reagent being applied to a support.
  • the carrier can comprise, for example, a test strip comprising an absorbent and / or swellable material which is wetted by the sample liquid to be examined.
  • a gel matrix with an enzyme-coenzyme complex embedded therein is used as the detection reagent.
  • the gel matrix preferably has a layer thickness of 50 ⁇ m, in particular ⁇ 5 ⁇ m, and is applied to a carrier, for example an at least partially optically transparent carrier.
  • the gel matrix can be a matrix comprising one or more soluble polymers, as in known dry test systems (eg AccuChek Active), and can be prepared by knife coating and drying.
  • the matrix is preferably a polymer based on photopolymerizable substances, such as acrylic monomers, for example acrylamide or / and acrylic acid esters, such as polyethylene glycol diacrylate, or vinyl aromatic monomers, for example 4-vinylbenzenesulfonic acid, or combinations thereof.
  • a liquid which contains the reagent comprising enzyme, photopolymerizable monomer and optionally coenzyme, photoinitiator and / or non-reactive constituents, can be applied to an at least partially optically transparent support, for example on a plastic film, and, for example, with UV Light is irradiated from the back, so that the monomer or monomers are polymerized on the support up to a predetermined layer thickness.
  • the layer thickness can be controlled by adding absorbent substances to the reagent and / or by the duration or intensity of the irradiation. Excess liquid reagent can be removed after the polymerization and used again (see, for example, FIG. 2).
  • the gel matrix can also be prepared by conventional coating procedures, the liquid reagent being applied to a support, there using suitable methods, e.g. with a doctor blade, brought to the desired thickness and then polymerized completely.
  • the enzyme After polymerization or embedding in the gel matrix, the enzyme is in a protected microenvironment. If the polymeric gel matrix is sufficiently crosslinked, the enzyme molecules are in an immobilized form. Low molecular weight substances or glucose or other analytes or coenzymes can diffuse freely through the polymer network.
  • the enzyme can either be polymerized into the matrix together with its coenzyme, or the matrix can be brought into contact with a solution of the coenzyme after the polymerization, so that the corresponding enzyme-coenzyme complex is formed.
  • concentration of the enzyme in the gel matrix is preferably chosen so high that a stoichiometric reaction with the analyte to be determined and a direct determination of the coenzyme changing by the reaction is possible.
  • the reaction consists of only one catalytic reaction, for example a redox reaction, which can take place in the millisecond or microsecond range.
  • the coenzyme modified by the reaction is optimally protected from interferences by binding to the active center of the enzyme and optionally also by incorporation into the gel matrix.
  • FIG 1 shows a first embodiment of the detection system according to the invention.
  • a reagent layer (2) for example a gel matrix with an enzyme-coenzyme complex, is applied to an optically transparent support (1).
  • the enzyme-coenzyme complex is in such a form that no regeneration of the coenzyme can take place during the analyte determination.
  • a sample (3) for example blood, is placed on the reagent layer.
  • the enzymatic reaction between the analyte contained in the sample (3) and the enzyme-coenzyme complex contained in the reagent layer (2) is determined by optical methods.
  • Light from a light source (4) for example a laser or an LED, is radiated onto the reagent layer (2) from behind (through the carrier).
  • FIG. 2 shows the manufacture of a detection system according to the invention.
  • a liquid reagent (12) is applied, for example, at a first position (13) to an optically transparent carrier (11), for example a plastic film.
  • the liquid reagent (12) is irradiated at a second position from below through the carrier (11) with light from a light source (14).
  • the carrier is moved in the direction (15) indicated by the arrow.
  • a polymerized reagent layer (16) is formed directly on the carrier (11). Excess liquid reagent is located above the polymer layer (16).
  • the thickness of the polymerized reagent layer (16) can be controlled by the reagent composition, the duration and intensity of the light irradiation and by the properties of the carrier (1 1).
  • FIG. 3 shows an embodiment of a fluorescence-based sensor from below.
  • a polymerized reagent layer for example produced by the continuous process in FIG. 2, can be cut and applied to a support (21) using known techniques. After the sample has been applied to the upper side, excitation light (23), e.g. UV light, radiated.
  • excitation light e.g. UV light
  • reagents can also be applied to a carrier.
  • An example of such an embodiment in the form of a disk is shown in FIG. 4.
  • reagent spots (32) are arranged on the optically transparent carrier (31).
  • FIGS. 5A and 5B show the fluorescence of a detection system according to the invention (glucose dehydrogenase and NAD + ) with increasing glucose concentration under a CCD camera.
  • Example 1 Stoichiometric detection of glucose in the glucose dehydrogenase (GlucDH) / NAD + system in a cuvette
  • the solution with the enzyme system does not fluoresce without glucose. Glucose and NAD + also do not produce fluorescence.
  • Example 2 Detection of glucose in the GlucDH / NAD + system in a polymer film
  • a suspension of the following substances was mixed in a plastic test tube.
  • the clear solution was poured onto a 1 25 mm thick corona-treated polycarbonate film and exposed for 20 min using a conventional exposure apparatus (Isel UV exposure device 2).
  • the film was briefly washed with water and then air dried.
  • the resulting layer thickness was ⁇ 2 ⁇ m.
  • a freshly prepared glucose / NAD + solution (GKL-3 solution, 300 mg / dl glucose, 1 ml / 6.4 mg NAD + ) was spotted on the film. A strong fluorescence was immediately visible under the UV lamp.
  • Example 3 Influencing the layer thickness by adding a UV adsorber
  • a polymer layer was produced which contained a blue dye (absorption maximum ⁇ 650 nm) for better recognition (recipe 2).
  • a yellow dye was added to the starting formulation as a UV absorber (formulation 3).
  • the mixture was homogenized by stirring and by ultrasonic bath treatment, distributed on a 140 ⁇ m Pokalon film (corona-treated, stage 4) with the pipette and exposed on a UV exposure device (Actina U4, W. Lemmen GmbH) for 1 min.
  • the resulting layer thickness was measured with a micrometer screw and was 240.5 ⁇ m.
  • the mixture was spread on a sheet as previously described and then polymerized.
  • the resulting layer thickness was measured with a micrometer screw and was 79.3 ⁇ m.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Polymerisation Methods In General (AREA)
  • Laminated Bodies (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Moulding By Coating Moulds (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Coating Of Shaped Articles Made Of Macromolecular Substances (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
EP03732396A 2002-05-16 2003-05-16 Verfahren und reagenzsystem mit nicht-regenerierbarem enzym-coenzym-komplex Withdrawn EP1504115A1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE10221846 2002-05-16
DE2002121845 DE10221845A1 (de) 2002-05-16 2002-05-16 Verfahren und Reagenzsystem mit nicht-regenerierbarem Enzym-Coenzym-Komplex
DE2002121846 DE10221846A1 (de) 2002-05-16 2002-05-16 Verfahren und Reagenzsystem mit inaktiviertem Enzym
DE10221840 2002-05-16
DE10221845 2002-05-16
DE2002121840 DE10221840A1 (de) 2002-05-16 2002-05-16 Verfahren zur Herstellung von Polymerschichten
PCT/EP2003/005178 WO2003097864A1 (de) 2002-05-16 2003-05-16 Verfahren und reagenzsystem mit nicht-regenerierbarem enzym-coenzym-komplex

Publications (1)

Publication Number Publication Date
EP1504115A1 true EP1504115A1 (de) 2005-02-09

Family

ID=29553736

Family Applications (3)

Application Number Title Priority Date Filing Date
EP03730061A Expired - Lifetime EP1504113B1 (de) 2002-05-16 2003-05-16 Verfahren zur herstellung von polymerschichten
EP03752757A Withdrawn EP1504116A1 (de) 2002-05-16 2003-05-16 Verfahren und reagenzsystem mit inaktiviertem enzym
EP03732396A Withdrawn EP1504115A1 (de) 2002-05-16 2003-05-16 Verfahren und reagenzsystem mit nicht-regenerierbarem enzym-coenzym-komplex

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP03730061A Expired - Lifetime EP1504113B1 (de) 2002-05-16 2003-05-16 Verfahren zur herstellung von polymerschichten
EP03752757A Withdrawn EP1504116A1 (de) 2002-05-16 2003-05-16 Verfahren und reagenzsystem mit inaktiviertem enzym

Country Status (15)

Country Link
US (3) US7341830B2 (ja)
EP (3) EP1504113B1 (ja)
JP (4) JP2005532796A (ja)
KR (2) KR101164048B1 (ja)
CN (2) CN1653189B (ja)
AT (1) ATE345396T1 (ja)
AU (3) AU2003232790A1 (ja)
BR (2) BR0311175A (ja)
CA (2) CA2493918C (ja)
DE (1) DE50305687D1 (ja)
DK (1) DK1504113T3 (ja)
ES (1) ES2275095T3 (ja)
HK (2) HK1081599A1 (ja)
MX (2) MXPA04011220A (ja)
WO (3) WO2003097859A2 (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341830B2 (en) * 2002-05-16 2008-03-11 Roche Diagnostics Operations, Inc. Method and reagent system having a non-regenerative enzyme-coenzyme complex
DE10325699B3 (de) * 2003-06-06 2005-02-10 Roche Diagnostics Gmbh System zur Analyse einer zu untersuchenden Probe und Verwendung eines solchen Systems
DE102004007983A1 (de) * 2004-02-18 2005-09-08 Roche Diagnostics Gmbh Testelement mit Einschicht-Reaktionsfilm
DE102004051830B4 (de) * 2004-10-25 2007-12-13 Roche Diagnostics Gmbh Multifunktionales Referenzsystem bei Analytbestimmungen durch Fluoreszenz
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
DE102005035461A1 (de) 2005-07-28 2007-02-15 Roche Diagnostics Gmbh Stabile NAD/NADH-Derivate
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
EP1928302B1 (en) 2005-09-30 2012-08-01 Intuity Medical, Inc. Fully integrated wearable or handheld monitor
CA2564666A1 (en) * 2005-10-25 2007-04-25 F. Hoffmann-La Roche Ag Fluorescence spectroscopy in absorbing media
GB0526051D0 (en) * 2005-12-21 2006-02-01 Oxford Biosensors Ltd Cholesterol sensor
EP1830177A1 (de) * 2006-03-02 2007-09-05 F. Hoffman-la Roche AG Integriertes Testelement
WO2007147086A2 (en) * 2006-06-14 2007-12-21 Brigham Young University Adsorption-resistant acrylic copolymer for fluidic devices
EP2022859A1 (de) * 2007-08-01 2009-02-11 Roche Diagnostics GmbH Verfahren und Vorrichtung zur Bestimmung der Konzentration eines Analyten mittels Fluoreszenzmessung
EP2093284A1 (de) 2008-02-19 2009-08-26 F.Hoffmann-La Roche Ag Stabilisierung von Dehydrogenasen mit stabilen Coenzymen
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
EP3639744B1 (en) 2008-06-06 2021-11-24 Intuity Medical, Inc. Blood glucose meter and method of operating
WO2009148624A1 (en) 2008-06-06 2009-12-10 Intuity Medical, Inc. Detection meter and mode of operation
AU2009269702B2 (en) 2008-07-11 2016-07-21 Universal Biosensors Pty Ltd Enhanced immunoassay sensor
EP2226007A1 (de) 2009-02-19 2010-09-08 Roche Diagnostics GmbH Testelementmagazin mit abgedeckten Testfeldern
EP2226008A1 (de) 2009-02-19 2010-09-08 Roche Diagnostics GmbH Verfahren zur Herstellung eines analytischen Magazins
EP2398909B1 (de) 2009-02-19 2015-07-22 F. Hoffmann-La Roche AG Schnelle reaktionskinetik von enzymen mit niedriger aktivität in trockenen chemieschichten
WO2010094427A2 (de) 2009-02-19 2010-08-26 Roche Diagnostics Gmbh Platzsparende magazinierung analytischer hilfsmittel
EP2292751A1 (de) 2009-08-20 2011-03-09 Roche Diagnostics GmbH Stabilisierung von Enzymen mit stabilen Coenzymen
WO2011065981A1 (en) 2009-11-30 2011-06-03 Intuity Medical, Inc. Calibration material delivery devices and methods
EP2362207A1 (de) * 2010-01-28 2011-08-31 F. Hoffmann-La Roche AG Messsystem und Messverfahren insbesondere zur Blutzuckerbestimmung
US9752990B2 (en) 2013-09-30 2017-09-05 Honeywell International Inc. Low-powered system for driving a fuel control mechanism
KR101530804B1 (ko) 2011-04-12 2015-06-22 에프. 호프만-라 로슈 아게 분석 보조기구
EP3750480B1 (en) 2011-08-03 2022-02-02 Intuity Medical, Inc. Body fluid sampling arrangement
EP2620507A1 (en) 2012-01-25 2013-07-31 Roche Diagnostics GmbH Method for the evaluation of the quality of a test element
KR101728597B1 (ko) 2012-04-19 2017-04-19 에프. 호프만-라 로슈 아게 혈액 내 분석물 농도를 결정하는 방법 및 디바이스
DE102013104906B4 (de) * 2013-05-13 2015-06-25 Brandenburgische Technische Universität Cottbus-Senftenberg Wasserfreie Immobilisierung von Enzymen
JP2016528175A (ja) 2013-06-04 2016-09-15 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｆｒｅｔに有用な新規化合物およびそれに関連する方法
US20170233787A1 (en) * 2014-08-05 2017-08-17 Becton, Dickinson And Company Methods and compositions for analyzing glucose-6-phosphate dehydrogenase activity in blood samples
KR102273051B1 (ko) 2014-10-21 2021-07-06 삼성디스플레이 주식회사 정공 수송용 재료 및 이를 이용한 유기 발광 소자
EP3339431A1 (en) 2016-12-22 2018-06-27 Roche Diabetes Care GmbH Glucose dehydrogenase variants with improved properties
EP3856139A1 (de) * 2018-09-24 2021-08-04 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. MAßGESCHNEIDERTE SCHICHTEN AUS CELLULOSE-DISPERSIONEN ZUM NACHWEIS VON ANALYTEN
US11579093B2 (en) * 2020-04-22 2023-02-14 SciLogica Corp. Optical component

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964974A (en) * 1972-09-28 1976-06-22 Merck Patent Gesellschaft Mit Beschrankter Haftung Enzymatic determination of glucose

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE638336A (ja) * 1964-12-21 1964-02-03
US4238565A (en) 1978-06-22 1980-12-09 Miles Laboratories, Inc. Specific binding assay with a prosthetic group as a label component
DE2924249C2 (de) * 1978-06-22 1989-04-27 Miles, Inc., Elkhart, Ind., Us Spezifische bindungs-untersuchungsmethode zur bestimmung eines liganden in einem fluessigen medium und reagentien zur durchfuehrung dieser methode
AT367796B (de) * 1979-10-29 1982-07-26 List Hans Verfahren zur bestimmung einer stoffkonzentration in einer loesung
US4451568A (en) * 1981-07-13 1984-05-29 Battelle Memorial Institute Composition for binding bioactive substances
DE3332144A1 (de) * 1982-09-06 1984-03-08 Konishiroku Photo Industry Co., Ltd., Tokyo Analytisches element
DE3477849D1 (en) * 1983-12-06 1989-05-24 Ici Plc Dry film resists
US4820399A (en) * 1984-08-31 1989-04-11 Shimadzu Corporation Enzyme electrodes
GB8608435D0 (en) 1986-04-07 1986-05-14 Cranfield Inst Of Tech Specific binding assays
JPH0710896B2 (ja) 1987-04-30 1995-02-08 第一工業製薬株式会社 高分子量カチオン性アクリル系重合体の製造方法
GB8718430D0 (en) * 1987-08-04 1987-09-09 Ici Plc Sensor
CA1322324C (en) * 1988-02-10 1993-09-21 Joel M. Blatt Self-indicating and improved resolution analyses employing stoichiometric chemical subtraction
US5340722A (en) * 1988-08-24 1994-08-23 Avl Medical Instruments Ag Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method
US5296305A (en) 1990-05-11 1994-03-22 Esslior International (Compagnie Generale D'optique) Method of fabricating a lens made of transparent polymer with modulated refracting index
GB9022304D0 (en) * 1990-10-15 1990-11-28 Ares Serono Res & Dev Ltd Assay technique
JP2977265B2 (ja) * 1990-11-19 1999-11-15 旭化成工業株式会社 感光性エラストマー構成体
DE4118880C2 (de) * 1991-06-08 1998-12-17 Fraunhofer Ges Forschung Verfahren zur selektiven Bestimmung der Konzentration gelöster Substanzen in enzymatischen Reaktionen
CA2100970A1 (en) * 1991-12-18 1993-06-19 Paul J. Buscemi Lubricous polyer network
DE59307720D1 (de) * 1992-03-23 1998-01-08 Siemens Ag Biosensor
JPH07115998A (ja) 1993-08-31 1995-05-09 Iatron Lab Inc Ｇｏｔ測定用試薬
JPH07115997A (ja) 1993-08-31 1995-05-09 Iatron Lab Inc Ｇｐｔ測定用試薬
US5447847A (en) * 1993-09-02 1995-09-05 Nissui Pharmaceutical Co., Ltd. Quantitative determination of pyruvic acid and quantitative analysis for component of living body making use of such determination
GB9404805D0 (en) * 1994-03-11 1994-04-27 Minnesota Mining & Mfg Novel developing agents for (photo)thermographic systems
US5691205A (en) 1994-06-23 1997-11-25 Canon Kabushiki Kaisha Fluorometric analysis of chloride ion and chemical sensor therefor
JP2986712B2 (ja) * 1995-05-01 1999-12-06 キヤノン株式会社 化学センサ、それを用いた塩化物イオン濃度の測定装置及び測定方法
DE4424179C2 (de) * 1994-07-08 1998-09-10 Biotechnolog Forschung Gmbh UV-polymerisierbare Enzympaste zur Herstellung von Dickschicht-Biosensoren und damit hergestellte Dickschicht-Biosensoren
JPH09248200A (ja) 1996-03-13 1997-09-22 Nissho Corp グルコース測定用試薬
US5863650A (en) 1997-05-05 1999-01-26 Bioengineered Materials, Inc. Interfacial coatings
JP2000035413A (ja) 1998-07-16 2000-02-02 Sapporo Imuno Diagnostic Laboratory:Kk 脱水素酵素と補酵素を用いたバイオセンサ
AT409307B (de) 1999-01-12 2002-07-25 Hoffmann La Roche Optisch-chemischer sensor
JP3869601B2 (ja) 1999-11-26 2007-01-17 株式会社トクヤマ ホモシステインの測定方法
US6635412B2 (en) * 2000-07-11 2003-10-21 Martin A. Afromowitz Method for fabricating 3-D structures with smoothly-varying topographic features in photo-sensitized epoxy resists
WO2002052045A1 (en) 2000-12-26 2002-07-04 Aviva Biosciences Active and biocompatible platforms prepared by polymerization of surface coating films
US20030087178A1 (en) * 2001-04-20 2003-05-08 Adrian Lungu Photopolymerizable element for use as a flexographic printing plate and a process for preparing the plate from the element
US7341830B2 (en) * 2002-05-16 2008-03-11 Roche Diagnostics Operations, Inc. Method and reagent system having a non-regenerative enzyme-coenzyme complex
US8602716B2 (en) 2003-11-10 2013-12-10 Brooks Automation, Inc. Semiconductor manufacturing process modules
JP4786451B2 (ja) 2005-07-28 2011-10-05 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Ｎａｄ／ｎａｄｈの安定化
EP1964927A1 (de) 2007-02-27 2008-09-03 F. Hoffmann-La Roche AG Chinone als Mediatoren für photometrische Teste
EP2022859A1 (de) 2007-08-01 2009-02-11 Roche Diagnostics GmbH Verfahren und Vorrichtung zur Bestimmung der Konzentration eines Analyten mittels Fluoreszenzmessung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964974A (en) * 1972-09-28 1976-06-22 Merck Patent Gesellschaft Mit Beschrankter Haftung Enzymatic determination of glucose

Also Published As

Publication number Publication date
US20080182324A1 (en) 2008-07-31
JP2005528896A (ja) 2005-09-29
JP2005532796A (ja) 2005-11-04
BR0309947A (pt) 2005-03-01
US20060099327A1 (en) 2006-05-11
MXPA04011103A (es) 2005-02-14
US7341830B2 (en) 2008-03-11
JP4656938B2 (ja) 2011-03-23
ES2275095T3 (es) 2007-06-01
HK1081600A1 (en) 2006-05-19
US8846132B2 (en) 2014-09-30
ATE345396T1 (de) 2006-12-15
AU2003232790A1 (en) 2003-12-02
HK1081599A1 (en) 2006-05-19
CN100439513C (zh) 2008-12-03
CN1653190A (zh) 2005-08-10
WO2003097859A2 (de) 2003-11-27
JP2009275233A (ja) 2009-11-26
DK1504113T3 (da) 2007-03-05
EP1504116A1 (de) 2005-02-09
CN1653189B (zh) 2010-12-15
BR0309947B1 (pt) 2013-11-26
BR0311175A (pt) 2005-03-15
DE50305687D1 (de) 2006-12-28
EP1504113A2 (de) 2005-02-09
WO2003097864A1 (de) 2003-11-27
WO2003097863A1 (de) 2003-11-27
US7951581B2 (en) 2011-05-31
KR101164048B1 (ko) 2012-07-18
CN1653189A (zh) 2005-08-10
AU2003240666B2 (en) 2009-04-23
US20050214891A1 (en) 2005-09-29
AU2003240666A1 (en) 2003-12-02
MXPA04011220A (es) 2005-02-14
CA2486950A1 (en) 2003-11-27
CA2493918A1 (en) 2003-11-27
AU2003240260B2 (en) 2008-05-22
CA2493918C (en) 2012-08-28
KR101002194B1 (ko) 2011-01-13
CA2486950C (en) 2013-07-30
EP1504113B1 (de) 2006-11-15
KR20040106531A (ko) 2004-12-17
JP5118288B2 (ja) 2013-01-16
JP2005528897A (ja) 2005-09-29
KR20040106530A (ko) 2004-12-17
AU2003240260A1 (en) 2003-12-02
WO2003097859A3 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
EP1504115A1 (de) Verfahren und reagenzsystem mit nicht-regenerierbarem enzym-coenzym-komplex
DE69714637T2 (de) Reagenzteststreifen zum Nachweis von Glukose im Blut
DE60210904T2 (de) Nitrit-stabilisierte Zusammensetzungen von Tetrazolium-Reagenz und Methoden derer Nutzung
DE3853029T2 (de) Sensor.
DE69917372T2 (de) Vorrichtung zur Quantifizierung von Substraten
DE69627097T2 (de) Blutglucose-Teststreifen mit reduzierter Sensitivität für Hämatokrit
DE3850919T2 (de) Diagnostisches Assay mit signalentwickelndem Agens auf dem Träger.
DE69019149T2 (de) Verfahren zur analyse, reagenszusammensetzung sowie deren verwendung bei der glukosebestimmung.
US20050036020A1 (en) Electrochemical sensor ink compositions, electrodes, and uses thereof
DE2532918C3 (de) Integrales analytisches Element für die Analyse von Flüssigkeiten
EP2794909B1 (de) Verfahren zur bestimmung einer analytkonzentration
DE602006000227T2 (de) Elektrodensubstrat, Detektionsvorrichtung mit dem Substrat, Kit mit der Detektionsvorrichtung und Detektionsverfahren unter Verwendung des Kits
AT390803B (de) Verfahren zur bestimmung der konzentration eines enzymsubstrates und sensor zur durchfuehrung des verfahrens
DE10221845A1 (de) Verfahren und Reagenzsystem mit nicht-regenerierbarem Enzym-Coenzym-Komplex
CH646792A5 (de) Testvorrichtung fuer die bestimmung von harnsaeure.
DE69736202T2 (de) Verfahren für die quantitative bestimmung von bikarbonationen in flüssigkeiten und vorrichtung für die trockenanalyse
WO2019238887A1 (de) Verfahren zur entfernung von gelöstem sauerstoff bei einem elektrochemischen biosensor der als sensorenzym eine oxidase verwendet
EP1445603A1 (de) Fluorimetrische Bestimmung von Analyten durch Amin-N-Oxide als Redoxindikatoren
DE10221846A1 (de) Verfahren und Reagenzsystem mit inaktiviertem Enzym
DE4118880C2 (de) Verfahren zur selektiven Bestimmung der Konzentration gelöster Substanzen in enzymatischen Reaktionen
EP1824586A1 (de) Verfahren zur beschichtung von membranen
DE10221840A1 (de) Verfahren zur Herstellung von Polymerschichten
EP0039027A1 (de) Chemische Verbindungen, Verfahren zu ihrer Herstellung, diese enthaltende Mittel sowie ihre Verwendung
EP0160847A1 (de) Analystisches Element zur Bestimmung von Glucose, glucosehaltigen Oligosacchariden und Harnsäure
DD143180A1 (de) Enzymelektrode zur nad(p)-bestimmung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041029

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100504

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140227